Sort   by:  
 Page size 
UnknownGenome-wide association study identifies Sjogren's risk loci with functional implications in immune and glandular cells.
Not available
S-EPMC9329286 | biostudies-literature
UnknownThe IRF5-TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share.
Not available
S-EPMC4275071 | biostudies-literature
UnknownGlycemia Reduction in Type 2 Diabetes - Microvascular and Cardiovascular Outcomes.
Not available
S-EPMC9832916 | biostudies-literature
UnknownGZMK+CD8+ T cells Target A Specific Acinar Cell Type in Sjogren's Disease.
Not available
S-EPMC10775371 | biostudies-literature
UnknownIdentification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study.
Not available
S-EPMC3322228 | biostudies-literature
UnknownMutations in ACTL6B Cause Neurodevelopmental Deficits and Epilepsy and Lead to Loss of Dendrites in Human Neurons.
Not available
S-EPMC6507050 | biostudies-literature
UnknownEfficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial.
Not available
S-EPMC4033144 | biostudies-literature
UnknownVariants in the <i>DDX6-CXCR5</i> autoimmune disease risk locus influence the regulatory network in immune cells and salivary gland.
Not available
S-EPMC11275775 | biostudies-literature
UnknownRole of MYH9 and APOL1 in African and non-African populations with lupus nephritis.
Not available
S-EPMC3330160 | biostudies-literature
UnknownAssociation of Baseline Characteristics With Insulin Sensitivity and β-Cell Function in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study Cohort.
Not available
S-EPMC7818323 | biostudies-literature
Sort   by:  
 Page size